Cardiovascular system medicine sales in Chile have exhibited significant fluctuations over the past decade, peaking in 2014 and 2022 with respective values of 8 and 7.6 units. Despite showing some positive growth in certain years, the overall trend has been downward, with actual sales in 2023 standing at 6.8 units, reflecting a -10.53% year-on-year decline. The average annual growth rate from 2018 to 2023 was 0.3%. Moving into the forecast period, sales are expected to decline modestly, with an anticipated average annual contraction of -0.6% from 2024 to 2028, culminating in a 6.5 unit sales figure by 2028.

Future trends to watch for include:

Innovations in cardiovascular treatments and potential impacts on market demand.
Changes in healthcare policies and funding in Chile.
Increasing prevalence of cardiovascular diseases in aging populations.
Potential effects of economic conditions on healthcare expenditure.